Publications by authors named "Yanxian Hou"

Article Synopsis
  • - A new nanocomposite, PAI@CB839, has been developed to treat triple-negative breast cancer (TNBC) using photothermal therapy, effectively delivering a glutaminase inhibitor to tumor cells in a targeted manner.
  • - The nanocomposite features a photothermal agent, IR780, which remains efficient even in water, and releases its cargo when exposed to the low-oxygen environment of tumors, damaging cancer cells upon irradiation.
  • - This approach not only enhances the anti-cancer immune response but also remodels the tumor microenvironment, potentially leading to reduced TNBC growth and metastasis, offering a promising strategy for TNBC treatment.
View Article and Find Full Text PDF

The non-peptide-based fluorescent probe QMC11 is capable of specifically targeting asparagine endopeptidase (AEP) and imaging cellular endogenous AEP. The motion of the probe can be restricted by AEP to activate fluorescence while keeping a low background signal.

View Article and Find Full Text PDF

Photodynamic therapy (PDT) destroys tumor cells mainly through singlet oxygen (O) generated by light-irradiated photosensitizers (PSs). However, the fleeting half-life of O greatly impairs PDT efficacy. Herein, we propose an unreported unsaturated fatty acid (UFA)-assisted PS co-assembly strategy to address this problem.

View Article and Find Full Text PDF

Co-amorphous solid dispersion (C-ASD) systems have attracted great attention to improve the solubility of poorly soluble drugs, but the selection of an appropriate stabilizer to stabilize amorphous forms is still a huge challenge. Herein, C-ASD system of two clinical combined used drugs (lacidipine (LCDP) and spironolactone (SPL)) as stabilizers to each other, was prepared by solvent evaporation method. The effects of variation in molar ratio of LCDP and SPL (3:1, 1:1, 1:3, 1:6, and 1:9) on the drug release characteristics were explored.

View Article and Find Full Text PDF

Overcoming blood-brain barrier (BBB) and targeting tumor cells are two key steps for glioma chemotherapy. By taking advantage of the specific expression of Na-coupled carnitine transporter 2 (OCTN2) on both brain capillary endothelial cells and glioma cells, l-carnitine conjugated poly(lactic-co-glycolic acid) nanoparticles (LC-PLGA NPs) were prepared to enable enhanced BBB permeation and glioma-cell targeting. Conjugation of l-carnitine significantly enhanced the uptake of PLGA nanoparticles in the BBB endothelial cell line hCMEC/D3 and the glioma cell line T98G.

View Article and Find Full Text PDF

For a highly hydrophobic and drug, it is difficult to formulate and solidify its nanocrystals with high drug loading and good redispersity. In this study, Allisartan Isoproxil was used as a model drug, and SDS was tested in combination with sugar alcohols to improve the drug loading and redispersity for its spray-dried nanocrystals, simultaneously. These spray-dried nanocrystals had high drug loading of 61.

View Article and Find Full Text PDF